Disease-vector mosquitoes transmit some of the most devastating diseases of humankind including malaria, dengue, and filariasis. The ability of different mosquito species to transmit these and other pathogens varies greatly and much of this variation in vectorial capacity can be attributed to the success or failure of the mosquito immune system to recognise and eliminate the pathogen. The availability of complete mosquito genome sequences has facilitated both large-scale and targeted experiments, which together with hypotheses generated from extensive comparative genomic analyses have driven dramatic advances in the understanding of vector biology. These studies have revealed key components and underlying mechanisms that constitute the dynamically evolving repertoire of the mosquito's systemic and local epithelial immunity [
1].
Recent genetic and biochemical studies of immune system responses to malaria parasite infections in
An. gambiae have linked three major antiparasitic factors together in a complement-like pathway that mediates parasite killing [
2,
3]. Two of these factors, LRIM1 and APL1C, are leucine-rich repeat (LRR) containing proteins that form a disulphide-bridged complex that interacts with the third factor, thioester-containing protein 1 (TEP1) a complement C3-like protein. The LRR proteins were initially identified as putative immune factors through microarray studies in
An. gambiae [
4]. Leucine-rich repeat immune protein 1 (LRIM1) was highly upregulated during infection with the rodent malaria parasite,
Plasmodium berghei, and RNAi-mediated silencing of
LRIM1 resulted in prominent increases in oocyst numbers, identifying LRIM1 as a key mosquito antagonist of parasite development [
5]. A population survey of West African
An. gambiae mosquitoes mapped the second LRR gene (
Anopheles-Plasmodium-responsive Leucine-rich repeat 1:
APL1, also called
LRIM2) to a genetic locus with major effects on the development and melanization of the human malaria parasite,
P. falciparum [
6]. Laboratory testing of
APL1 produced similar effects to
LRIM1 silencing, with significantly increased numbers of developing
P. berghei oocysts.
Similarly to the effects of silencing
LRIM1 and
APL1, knocking down
TEP1 led to dramatically increased numbers of developing
P. berghei oocysts [
7]. TEP1 binds to bacterial surfaces promoting phagocytosis [
8,
9] and to the surface of invading ookinetes resulting in their lysis or melanization [
7], resembling the roles of vertebrate complement factors. Testing orthologues of all three factors in the non-vector mosquito,
An. quadriannulatus species A, identified them as key factors in the lysis and melanization responses that these mosquitoes naturally mount against malaria parasites [
10].
LRIM1,
APL1, and
TEP1 are also important in mediating
An. gambiae immune responses to infections with the rodent malaria parasite,
P. yoelii [
11]. The
An. gambiae APL1 genomic locus in fact encompasses three distinct genes (
APL1A,
APL1B and
APL1C) of which only the product of
APL1C acts as a
P. berghei antagonist [
12]. While APL1C functions in immunity against rodent malaria parasites, the
APL1A gene product protects
An. gambiae against
P. falciparum [
13]. The LRIM1/APL1C protein complex circulates in the mosquito hemolymph where it is shown to interact with the processed form of TEP1 and promote its subsequent localization on the surface of midgut-invading
P. berghei parasites [
2,
3]. In the absence of the LRIM1/APL1C complex, the processed form of TEP1 is found sequestered on self tissues [
2]. These studies established the cooperative roles of three key parasite antagonists in the mosquito hemolymph functioning as a complement-like system to achieve targeted pathogen elimination.
LRIM1 and APL1C exhibit several common protein sequence features in addition to their LRRs including signal peptides, patterns of cysteine residues, and coiled-coil domains that identify them as founding members of a family of related mosquito LRR proteins. The relative positioning of only a few key amino acids defines the structural integrity of both LRR and coiled-coil domains, tolerating high levels of sequence variation that may obscure homologous sequence relationships within the superfamily of LRR-containing proteins. This is in contrast to the relatively well-defined family of thioester-containing proteins, which despite the elevated amino acid substitution levels [
14] and exceptional allelic polymorphism [
15] exhibited by TEP1, form a distinct clade within a superfamily including the pan-protease inhibitors, α-macroglobulins, and the vertebrate complement factors [
16,
17].
Here we present the results of a comprehensive computational comparative analysis of the sequence characteristics that define the family of LRIM proteins in three disease-vector mosquito species. Predicted structural features suggest an architecture that confers diverse recognition receptor properties with the ability to form multimeric complexes and interact with other components of the mosquito immune system.